Sir,

Natural products are the logical starting point for discovering new drugs as evidenced by the discovery of penicillin[@ref1]. More than 60 per cent of approved antitumour drugs are derived from natural compounds[@ref2][@ref3]. Drugs with anticancer properties including anthracycline, bleomycin, actinomycin and mitomycin have been isolated from actinobacteria[@ref4][@ref5]. We have earlier reported isolation and characterization of bioactive metabolites for the first time from *Nocardia levis* MK-VL_113 and *Streptomyces tendae* TK-VL_333[@ref6]--[@ref10]. In this study these bioactive metabolites were tested for cytotoxicity which is the pre-requisite assay for testing anticancer activity.

For the extraction and purification of bioactive metabolites produced by *N. levis* and *S. tendae*, the pure cultures of the strains grown in seed medium (Yeast extract-malt extract-dextrose broth) were transferred individually to optimized fermentation media (Sucrose-tryptone broth for *N. levis*[@ref6] and galactose-tyrosine broth for *S. tendae*[@ref7] under aseptic conditions. The fermentation process was turned off after 96 h of incubation and the culture broths were collected, extracted with ethyl acetate and evaporated to vacuum. The crude residues thus obtained were subjected to purification by using chromatographic techniques (silica gel column, thin layer and semi-preparative high performance liquid chromatography) and the structure of the pure bioactive compounds was elucidated and confirmed on the basis of Fourier transform infrared (FTIR), Electron impact mass (EIMS)/Electron spray ionization mass (ESIMS) spectrometry and nuclear magnetic resonance (^1^H NMR and ^13^C NMR) spectroscopy[@ref8]--[@ref10].

Screening of secondary metabolites obtained from *N. levis* led to the identification of bioactive compounds namely 1-phenylbut-3-ene-2-ol, bis-(2-ethylhexyl) phthalate, bis-(5-ethylheptyl) phthalate and a partially purified fraction containing phenylethyl alcohol, dibutyl phthalate and 1,2-benzenedicarboxylic acid, 3-nitro[@ref8][@ref9]. Five bioactive compounds namely 1*H*-indole-3-carboxylic acid, 2,3-dihydroxy-5-(hydroxymethyl) benzaldehyde, 4-(4-hydroxyphenoxy) butan-2-one, acetic acid-2-hydroxy-6-(3-oxo-butyl)-phenyl ester and 8-methyl decanoic acid were purified from the culture broth of *S. tendae*[@ref10]. No information is available on the production of these bioactive metabolites by *Streptomyces*. Hence, these bioactive metabolites isolated from *N. levis* MK-VL_113 and *S. tendae* TK-VL_333 were tested for cytotoxic activity using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay[@ref11].

Cell lines *viz*., U-937 (Human leukemic monocyte lymphoma cell line) and HL-60 (Human promyelocytic leukemia cell line) procured from National Centre for Cell Science, Pune, India were cultured on RPMI-1640 (Hi-media®, Mumbai) medium supplemented with 10 per cent (v/v) foetal bovine serum, 1 mM NaHCO~3~, 2 mM L-glutamine and penicillin-streptomycin in a humidified atmosphere (95%) with 5 per cent CO~2~ at 37°C. Cells of U-937 and HL-60 (2 × 10^4^ cells per well) were seeded in each well of 96-well microtiter plate containing 0.1 ml of medium. After overnight incubation, the cells were treated with different test concentrations of bioactive compounds (0-200 μg/ml) of the strains at identical conditions with three replicates of each concentration. After 24 h of incubation, the cell viability was assessed by adding 10 μl of MTT (5 mg/ml) per well and the plates were incubated in a CO~2~ incubator at 37°C for 4 h. The formazan crystals formed in the cells were dissolved with 100 μl of 0.1 per cent DMSO and the rate of colour development was measured at 570 nm in a spectrophotometer (Spectra MAX Plus, Molecular Devices, supported by SOFTmax PRO-3.0, USA). The inhibition of cell viability (IC~50~) was determined with reference to that of etoposide (standard).

Bioactive compounds produced by *N. levis* and *S. tendae* showed cytotoxic activity against U-937 and HL-60 cell lines. Among these, NL~1~ and NL~2~ from *N. levis* and T~1~ and T~5~ from *S. tendae* exhibited high cytotoxicity when compared to the others ([Table](#T1){ref-type="table"}). However, their activity was less when compared to etoposide (positive control). Actinobacteria particularly *Streptomyces* spp. are known to produce a number of potent cytotoxic compounds including anthracyclines, FCE 21424, FCE 24366 and FCE 24367[@ref12], saptomycins[@ref13], cremeomycin[@ref14], clecarmycins[@ref15], actinomycins G~2~-G~6~[@ref16], moromycins A and B, saquayamycin B and fridamycin D[@ref17] while brasiliquinones A, B and C[@ref18], nocardiones A and B[@ref19]and chemomicin A[@ref20] were recorded from *Nocardia* spp. Keeping the potentiality of the actinobacterial metabolites as anticancer agents, the bioactive metabolites of *N. levis* and *S. tendae* showing moderate cytotoxic activity against the cell lines, U-937 and HL-60 may be used as model systems for the preparation of anticancer drugs by testing further anticancer assays.
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